目次

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
Exhibit 06: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size
4.1 Global pneumococcal vaccine market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on global pneumococcal vaccine market 2017 - 2021 ($ million)
4.2 Type Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Type Segment 2017 - 2021 ($ million)
4.3 Distribution Channel Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Type
6.1 Market segments
Exhibit 30: Chart on Type - Market share 2022-2027 (%)
Exhibit 31: Data Table on Type - Market share 2022-2027 (%)
6.2 Comparison by Type
Exhibit 32: Chart on Comparison by Type
Exhibit 33: Data Table on Comparison by Type
6.3 Pneumococcal conjugate vaccine - Market size and forecast 2022-2027
Exhibit 34: Chart on Pneumococcal conjugate vaccine - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Pneumococcal conjugate vaccine - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Pneumococcal conjugate vaccine - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Pneumococcal conjugate vaccine - Year-over-year growth 2022-2027 (%)
6.4 Pneumococcal polysaccharide vaccine - Market size and forecast 2022-2027
Exhibit 38: Chart on Pneumococcal polysaccharide vaccine - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Pneumococcal polysaccharide vaccine - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Pneumococcal polysaccharide vaccine - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Pneumococcal polysaccharide vaccine - Year-over-year growth 2022-2027 (%)
6.5 Market opportunity by Type
Exhibit 42: Market opportunity by Type ($ million)
Exhibit 43: Data Table on Market opportunity by Type ($ million)

7 Market Segmentation by Distribution Channel
7.1 Market segments
Exhibit 44: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibit 45: Data Table on Distribution Channel - Market share 2022-2027 (%)
7.2 Comparison by Distribution Channel
Exhibit 46: Chart on Comparison by Distribution Channel
Exhibit 47: Data Table on Comparison by Distribution Channel
7.3 Non-governmental organizations - Market size and forecast 2022-2027
Exhibit 48: Chart on Non-governmental organizations - Market size and forecast 2022-2027 ($ million)
Exhibit 49: Data Table on Non-governmental organizations - Market size and forecast 2022-2027 ($ million)
Exhibit 50: Chart on Non-governmental organizations - Year-over-year growth 2022-2027 (%)
Exhibit 51: Data Table on Non-governmental organizations - Year-over-year growth 2022-2027 (%)
7.4 Government authorities - Market size and forecast 2022-2027
Exhibit 52: Chart on Government authorities - Market size and forecast 2022-2027 ($ million)
Exhibit 53: Data Table on Government authorities - Market size and forecast 2022-2027 ($ million)
Exhibit 54: Chart on Government authorities - Year-over-year growth 2022-2027 (%)
Exhibit 55: Data Table on Government authorities - Year-over-year growth 2022-2027 (%)
7.5 Distribution partner companies - Market size and forecast 2022-2027
Exhibit 56: Chart on Distribution partner companies - Market size and forecast 2022-2027 ($ million)
Exhibit 57: Data Table on Distribution partner companies - Market size and forecast 2022-2027 ($ million)
Exhibit 58: Chart on Distribution partner companies - Year-over-year growth 2022-2027 (%)
Exhibit 59: Data Table on Distribution partner companies - Year-over-year growth 2022-2027 (%)
7.6 Market opportunity by Distribution Channel
Exhibit 60: Market opportunity by Distribution Channel ($ million)
Exhibit 61: Data Table on Market opportunity by Distribution Channel ($ million)

8 Customer Landscape
8.1 Customer landscape overview
Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 63: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 64: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 65: Chart on Geographic comparison
Exhibit 66: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 67: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 68: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 69: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 70: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 71: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 72: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 73: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 74: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 75: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 76: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 77: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 78: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 83: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 84: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 85: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 86: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 Germany - Market size and forecast 2022-2027
Exhibit 87: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 88: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 89: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 90: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.9 UK - Market size and forecast 2022-2027
Exhibit 91: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 92: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 93: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 94: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.10 Canada - Market size and forecast 2022-2027
Exhibit 95: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 96: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 97: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibit 98: Data Table on Canada - Year-over-year growth 2022-2027 (%)
9.11 China - Market size and forecast 2022-2027
Exhibit 99: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 100: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 101: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 102: Data Table on China - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 103: Market opportunity By Geographical Landscape ($ million)
Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 105: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends

11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 107: Overview on factors of disruption
11.4 Industry risks
Exhibit 108: Impact of key risks on business

12 Vendor Analysis
12.1 Vendors covered
Exhibit 109: Vendors covered
12.2 Market positioning of vendors
Exhibit 110: Matrix on vendor position and classification
12.3 Astellas Pharma Inc.
Exhibit 111: Astellas Pharma Inc. - Overview
Exhibit 112: Astellas Pharma Inc. - Product / Service
Exhibit 113: Astellas Pharma Inc. - Key news
Exhibit 114: Astellas Pharma Inc. - Key offerings
12.4 Biological E. Ltd.
Exhibit 115: Biological E. Ltd. - Overview
Exhibit 116: Biological E. Ltd. - Product / Service
Exhibit 117: Biological E. Ltd. - Key offerings
12.5 CSL Ltd.
Exhibit 118: CSL Ltd. - Overview
Exhibit 119: CSL Ltd. - Business segments
Exhibit 120: CSL Ltd. - Key offerings
Exhibit 121: CSL Ltd. - Segment focus
12.6 GlaxoSmithKline Plc
Exhibit 122: GlaxoSmithKline Plc - Overview
Exhibit 123: GlaxoSmithKline Plc - Business segments
Exhibit 124: GlaxoSmithKline Plc - Key news
Exhibit 125: GlaxoSmithKline Plc - Key offerings
Exhibit 126: GlaxoSmithKline Plc - Segment focus
12.7 Merck and Co. Inc.
Exhibit 127: Merck and Co. Inc. - Overview
Exhibit 128: Merck and Co. Inc. - Business segments
Exhibit 129: Merck and Co. Inc. - Key news
Exhibit 130: Merck and Co. Inc. - Key offerings
Exhibit 131: Merck and Co. Inc. - Segment focus
12.8 Panacea Biotec Ltd.
Exhibit 132: Panacea Biotec Ltd. - Overview
Exhibit 133: Panacea Biotec Ltd. - Product / Service
Exhibit 134: Panacea Biotec Ltd. - Key offerings
12.9 Petrovax
Exhibit 135: Petrovax - Overview
Exhibit 136: Petrovax - Product / Service
Exhibit 137: Petrovax - Key offerings
12.10 Pfizer Inc.
Exhibit 138: Pfizer Inc. - Overview
Exhibit 139: Pfizer Inc. - Product / Service
Exhibit 140: Pfizer Inc. - Key news
Exhibit 141: Pfizer Inc. - Key offerings
12.11 Sanofi
Exhibit 142: Sanofi - Overview
Exhibit 143: Sanofi - Business segments
Exhibit 144: Sanofi - Key news
Exhibit 145: Sanofi - Key offerings
Exhibit 146: Sanofi - Segment focus
12.12 Serum Institute of India Pvt. Ltd.
Exhibit 147: Serum Institute of India Pvt. Ltd. - Overview
Exhibit 148: Serum Institute of India Pvt. Ltd. - Product / Service
Exhibit 149: Serum Institute of India Pvt. Ltd. - Key offerings
12.13 Shenzhen Kangtai Biological Products Co. Ltd.
Exhibit 150: Shenzhen Kangtai Biological Products Co. Ltd. - Overview
Exhibit 151: Shenzhen Kangtai Biological Products Co. Ltd. - Product / Service
Exhibit 152: Shenzhen Kangtai Biological Products Co. Ltd. - Key offerings
12.14 Sinovac Biotech Ltd.
Exhibit 153: Sinovac Biotech Ltd. - Overview
Exhibit 154: Sinovac Biotech Ltd. - Product / Service
Exhibit 155: Sinovac Biotech Ltd. - Key offerings
12.15 SK Inc.
Exhibit 156: SK Inc. - Overview
Exhibit 157: SK Inc. - Product / Service
Exhibit 158: SK Inc. - Key offerings
12.16 Vaxcyte Inc.
Exhibit 159: Vaxcyte Inc. - Overview
Exhibit 160: Vaxcyte Inc. - Product / Service
Exhibit 161: Vaxcyte Inc. - Key offerings
12.17 Walvax Biotechnology Co. Ltd.
Exhibit 162: Walvax Biotechnology Co. Ltd. - Overview
Exhibit 163: Walvax Biotechnology Co. Ltd. - Product / Service
Exhibit 164: Walvax Biotechnology Co. Ltd. - Key offerings

13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 165: Inclusions checklist
Exhibit 166: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 167: Currency conversion rates for US$
13.4 Research methodology
Exhibit 168: Research methodology
Exhibit 169: Validation techniques employed for market sizing
Exhibit 170: Information sources
13.5 List of abbreviations
Exhibit 171: List of abbreviations

Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Type
Exhibits6: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on global pneumococcal vaccine market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - Type Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Type - Market share 2022-2027 (%)
Exhibits31: Data Table on Type - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Type
Exhibits33: Data Table on Comparison by Type
Exhibits34: Chart on Pneumococcal conjugate vaccine - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Pneumococcal conjugate vaccine - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Pneumococcal conjugate vaccine - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Pneumococcal conjugate vaccine - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Pneumococcal polysaccharide vaccine - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Pneumococcal polysaccharide vaccine - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Pneumococcal polysaccharide vaccine - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Pneumococcal polysaccharide vaccine - Year-over-year growth 2022-2027 (%)
Exhibits42: Market opportunity by Type ($ million)
Exhibits43: Data Table on Market opportunity by Type ($ million)
Exhibits44: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibits45: Data Table on Distribution Channel - Market share 2022-2027 (%)
Exhibits46: Chart on Comparison by Distribution Channel
Exhibits47: Data Table on Comparison by Distribution Channel
Exhibits48: Chart on Non-governmental organizations - Market size and forecast 2022-2027 ($ million)
Exhibits49: Data Table on Non-governmental organizations - Market size and forecast 2022-2027 ($ million)
Exhibits50: Chart on Non-governmental organizations - Year-over-year growth 2022-2027 (%)
Exhibits51: Data Table on Non-governmental organizations - Year-over-year growth 2022-2027 (%)
Exhibits52: Chart on Government authorities - Market size and forecast 2022-2027 ($ million)
Exhibits53: Data Table on Government authorities - Market size and forecast 2022-2027 ($ million)
Exhibits54: Chart on Government authorities - Year-over-year growth 2022-2027 (%)
Exhibits55: Data Table on Government authorities - Year-over-year growth 2022-2027 (%)
Exhibits56: Chart on Distribution partner companies - Market size and forecast 2022-2027 ($ million)
Exhibits57: Data Table on Distribution partner companies - Market size and forecast 2022-2027 ($ million)
Exhibits58: Chart on Distribution partner companies - Year-over-year growth 2022-2027 (%)
Exhibits59: Data Table on Distribution partner companies - Year-over-year growth 2022-2027 (%)
Exhibits60: Market opportunity by Distribution Channel ($ million)
Exhibits61: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits63: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits64: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits65: Chart on Geographic comparison
Exhibits66: Data Table on Geographic comparison
Exhibits67: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits68: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits69: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits70: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits71: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits72: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits73: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits74: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits75: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits76: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits77: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits100: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits101: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits103: Market opportunity By Geographical Landscape ($ million)
Exhibits104: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits105: Impact of drivers and challenges in 2022 and 2027
Exhibits106: Overview on Criticality of inputs and Factors of differentiation
Exhibits107: Overview on factors of disruption
Exhibits108: Impact of key risks on business
Exhibits109: Vendors covered
Exhibits110: Matrix on vendor position and classification
Exhibits111: Astellas Pharma Inc. - Overview
Exhibits112: Astellas Pharma Inc. - Product / Service
Exhibits113: Astellas Pharma Inc. - Key news
Exhibits114: Astellas Pharma Inc. - Key offerings
Exhibits115: Biological E. Ltd. - Overview
Exhibits116: Biological E. Ltd. - Product / Service
Exhibits117: Biological E. Ltd. - Key offerings
Exhibits118: CSL Ltd. - Overview
Exhibits119: CSL Ltd. - Business segments
Exhibits120: CSL Ltd. - Key offerings
Exhibits121: CSL Ltd. - Segment focus
Exhibits122: GlaxoSmithKline Plc - Overview
Exhibits123: GlaxoSmithKline Plc - Business segments
Exhibits124: GlaxoSmithKline Plc - Key news
Exhibits125: GlaxoSmithKline Plc - Key offerings
Exhibits126: GlaxoSmithKline Plc - Segment focus
Exhibits127: Merck and Co. Inc. - Overview
Exhibits128: Merck and Co. Inc. - Business segments
Exhibits129: Merck and Co. Inc. - Key news
Exhibits130: Merck and Co. Inc. - Key offerings
Exhibits131: Merck and Co. Inc. - Segment focus
Exhibits132: Panacea Biotec Ltd. - Overview
Exhibits133: Panacea Biotec Ltd. - Product / Service
Exhibits134: Panacea Biotec Ltd. - Key offerings
Exhibits135: Petrovax - Overview
Exhibits136: Petrovax - Product / Service
Exhibits137: Petrovax - Key offerings
Exhibits138: Pfizer Inc. - Overview
Exhibits139: Pfizer Inc. - Product / Service
Exhibits140: Pfizer Inc. - Key news
Exhibits141: Pfizer Inc. - Key offerings
Exhibits142: Sanofi - Overview
Exhibits143: Sanofi - Business segments
Exhibits144: Sanofi - Key news
Exhibits145: Sanofi - Key offerings
Exhibits146: Sanofi - Segment focus
Exhibits147: Serum Institute of India Pvt. Ltd. - Overview
Exhibits148: Serum Institute of India Pvt. Ltd. - Product / Service
Exhibits149: Serum Institute of India Pvt. Ltd. - Key offerings
Exhibits150: Shenzhen Kangtai Biological Products Co. Ltd. - Overview
Exhibits151: Shenzhen Kangtai Biological Products Co. Ltd. - Product / Service
Exhibits152: Shenzhen Kangtai Biological Products Co. Ltd. - Key offerings
Exhibits153: Sinovac Biotech Ltd. - Overview
Exhibits154: Sinovac Biotech Ltd. - Product / Service
Exhibits155: Sinovac Biotech Ltd. - Key offerings
Exhibits156: SK Inc. - Overview
Exhibits157: SK Inc. - Product / Service
Exhibits158: SK Inc. - Key offerings
Exhibits159: Vaxcyte Inc. - Overview
Exhibits160: Vaxcyte Inc. - Product / Service
Exhibits161: Vaxcyte Inc. - Key offerings
Exhibits162: Walvax Biotechnology Co. Ltd. - Overview
Exhibits163: Walvax Biotechnology Co. Ltd. - Product / Service
Exhibits164: Walvax Biotechnology Co. Ltd. - Key offerings
Exhibits165: Inclusions checklist
Exhibits166: Exclusions checklist
Exhibits167: Currency conversion rates for US$
Exhibits168: Research methodology
Exhibits169: Validation techniques employed for market sizing
Exhibits170: Information sources
Exhibits171: List of abbreviations